KLRK1 and neoplasm: Thus, primary tumors frequently express NKG2D ligands but, as in the case of viral infections, several mechanisms have been identified that elude the detection and elimination of tumor cells by the immune system, suggesting an NKG2D-mediated immune editing of the tumor (14).